Home - Products - GPCR/G Protein - cAMP - Adenosine receptor A1 antagonist 5

Adenosine receptor A1 antagonist 5

CAS No. 85872-53-3

Adenosine receptor A1 antagonist 5( —— )

Catalog No. M33817 CAS No. 85872-53-3

Adenosine receptor A1 antagonist 5 acts as an adenosine antagonist, is an oxypurine, acts as an insecticide and pest control agent, and has an inhibitory effect on elevated blood pressure.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 95 In Stock
10MG 140 In Stock
25MG 239 In Stock
50MG 334 In Stock
100MG 461 In Stock
200MG 620 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Adenosine receptor A1 antagonist 5
  • Note
    Research use only, not for human use.
  • Brief Description
    Adenosine receptor A1 antagonist 5 acts as an adenosine antagonist, is an oxypurine, acts as an insecticide and pest control agent, and has an inhibitory effect on elevated blood pressure.
  • Description
    NPC 200 is a potent and selective antagonist of Adenosine A1 Receptor. NPC 200 reverses NECA-induced left and right atrial depression with EC50s of 1.08 and 2.03 μM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    cAMP
  • Recptor
    cAMP
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    85872-53-3
  • Formula Weight
    312.37
  • Molecular Formula
    C17H20N4O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC)N1C2=C(NC(=N2)C3=CC=CC=C3)C(=O)N(CCC)C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. P. V. Kaplita, et al. NPC 205 is a potent and selective adenosine A1, receptor antagonist: Correlation among receptor binding, biochemical, and physiological assays. , 20(4), 429–443.
molnova catalog
related products
  • Flumatinib

    Flumatinib is an orally bioavailable tyrosine kinase inhibitor flumatinib, with potential antineoplastic activity.

  • ESI-05

    ESI-05 is a specific EPAC2 (exchange protein directly activated by cAMP 2) antagonist (IC50: 0.4 μM). ESI-05 inhibits cAMP-mediated activation of EPAC2, as well as EAPC2, mediated Rap1 activation.

  • CE3F4

    CE3F4 is a selective antagonist of exchange protein directly activated by cAMP.